MedTrace Logo

Serum Proteomic Profiling for the Early Diagnosis of Colorectal Cancer

NCT01604798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 547

Last updated 2012-05-24

No results posted yet for this study

Summary

No ideal serum biomarker currently exists for the early diagnosis of colorectal cancer (CRC). Therefore, it is urgent that accurate and reliable serum biomarkers be identified.

Conditions

  • Colorectal Neoplasms

Interventions

OTHER

Serum proteomics

magnetic bead-based fractionation coupled with matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Jianmin Xu, M.D.,Ph.D. · Fudan University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01604798 on ClinicalTrials.gov